| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/11/2012 | CN102309564A Anti-stress drug used for aquatic livestock and its preparation method |
| 01/11/2012 | CN102309562A Preparation method of taste-masked suspension granules of Gegenqinlian decoction |
| 01/11/2012 | CN102309540A Low-sugar-content twotooth achyranthes root mixture |
| 01/11/2012 | CN102309536A Ointment for treating frostbite and rahagades and preparation method of ointment |
| 01/11/2012 | CN102309534A Chinese medicinal herb composition for treating burns and scalds, its preparation method and application |
| 01/11/2012 | CN102309527A Drug for controlling death stealing of Penaeus vannamei Boone and preparation method thereof |
| 01/11/2012 | CN102309523A Dentoidin sponginum and preparation method thereof |
| 01/11/2012 | CN102309522A Deproteinised porcine blood extract oral paste and its preparation technology |
| 01/11/2012 | CN102309499A Baohuoside-I phospholipid complex and its preparation method |
| 01/11/2012 | CN102309498A Medicinal composition of baohuoside I |
| 01/11/2012 | CN102309488A Itraconazole medicinal composition and preparation method thereof |
| 01/11/2012 | CN102309482A Clopidogrel hydrogensulfate composition and preparation method thereof |
| 01/11/2012 | CN102309476A Fenofibrate composition |
| 01/11/2012 | CN102309475A Levocarnitine for injection and preparation method thereof |
| 01/11/2012 | CN102309470A Cold oil and preparation process thereof |
| 01/11/2012 | CN102309469A Baohuoside I dry powder inhalant as well as preparation method and application thereof |
| 01/11/2012 | CN102309467A Preparation method of atorvastatin calcium capsule |
| 01/11/2012 | CN102309466A Oral quetiapine sustained-release tablet |
| 01/11/2012 | CN102309465A Sustained release tablet containing donepezil hydrochloride active component as well as preparation method and application thereof |
| 01/11/2012 | CN102309464A Folic acid tablet and preparation method thereof |
| 01/11/2012 | CN102309463A Ganciclovir tablet composition and its preparation method |
| 01/11/2012 | CN102309461A Pyridostigmine bromide odor masking dispersible tablets and preparation method thereof |
| 01/11/2012 | CN102309460A Pyridostigmine bromide odor masking orally disintegrating tablets and preparation method thereof |
| 01/11/2012 | CN102309459A Method for preparing manidipine frozen powder injection |
| 01/11/2012 | CN102309458A Sodium alginate crosslinking moxifloxacin sustained-release microspheres and preparation method and application thereof, and vascular target suppository containing microsphere |
| 01/11/2012 | CN102309457A Preparation method for nucleic acid nano-particle wrapping pharmacological active substances |
| 01/11/2012 | CN102309454A Preparation method of econazole nitrate/polyacrylic resin cationic nanoparticles |
| 01/11/2012 | CN102309453A Exenatide multivesicular liposome and preparation method thereof |
| 01/11/2012 | CN102309452A Fluvastatin sodium liposome solid preparation |
| 01/11/2012 | CN102309451A Nifuratel liposome solid preparation |
| 01/11/2012 | CN102309450A Doxycycline hydrochloride liposome injection |
| 01/11/2012 | CN102309448A Pulmonary delivery ciprofloxacin pharmaceutical composition and preparation method thereof |
| 01/11/2012 | CN102309447A Oxybutynin hydrochloride-containing self-adhesive spraying transdermal composition and preparation method thereof |
| 01/11/2012 | CN102309444A Novel docetaxel injection pharmaceutical composition and application thereof |
| 01/11/2012 | CN102309443A Small cluster water zinc supplementation oral liquid, and preparation method and application thereof |
| 01/11/2012 | CN102309442A Ambroxol hydrochloride oral aqueous composition and preparation method thereof |
| 01/11/2012 | CN102309441A Silymarin medicinal composition wrapper and preparation method thereof |
| 01/11/2012 | CN102309440A Method for producing ganciclovir glucose injection |
| 01/11/2012 | CN102309439A Traumatic injury burn cream and preparation process thereof |
| 01/11/2012 | CN102309438A Midazolam medicament composition as well as preparation method and application thereof |
| 01/11/2012 | CN102085187B Montelukast sodium liposome solid preparation |
| 01/11/2012 | CN102078300B Solid preparation of Torasemide liposome |
| 01/11/2012 | CN102068453B Stable complex vitamin composition and preparation method thereof |
| 01/11/2012 | CN102028927B Externally applied emplastrum for treating anxious chronic bronchitis and preparation method thereof |
| 01/11/2012 | CN102008440B Solid preparation of atorvastatin calcium liposome |
| 01/11/2012 | CN102008435B Avian decoquinate oral suspension and preparation method thereof |
| 01/11/2012 | CN101947321B Heat-resisting and freeze-drying protector for live vaccine and preparation method thereof as well as live newcastle disease vaccine |
| 01/11/2012 | CN101912403B Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection |
| 01/11/2012 | CN101912356B Aztreonam/arginine medicinal composition lipid microsphere injection |
| 01/11/2012 | CN101843613B Vitamin EC chewable tablets with high stability and preparation method thereof |
| 01/11/2012 | CN101816640B Prasugrel liposome solid preparation |
| 01/11/2012 | CN101804035B Lansoprazole preparation for injection and preparation method thereof |
| 01/11/2012 | CN101781357B Polypeptide for detecting human cancer cells, and application thereof |
| 01/11/2012 | CN101775372B Anti-testicle-protein hT279 antibody or antibody fragment and application thereof |
| 01/11/2012 | CN101773508B Stable Trifusal pharmaceutical composition |
| 01/11/2012 | CN101721715B Compound of tumor targeted nonviral gene vector and plasmid DNA and preparation method thereof |
| 01/11/2012 | CN101721710B Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method |
| 01/11/2012 | CN101703752B Medicinal composition spray or aerosol for treating whitevein and preparation method thereof |
| 01/11/2012 | CN101700225B Fat emulsion injection and production method thereof |
| 01/11/2012 | CN101637456B Suspension powder injection of cefamandole nafate and new application thereof |
| 01/11/2012 | CN101607088B Method for synthesizing magnetic layered composite hydroxide |
| 01/11/2012 | CN101606915B Novel pharmaceutical formulations of modafinil |
| 01/11/2012 | CN101543631B Microspherical substrate containing beeswax, pharmaceutical composition containing microspherical substrate and application thereof |
| 01/11/2012 | CN101491679B Soft-capsule coating method |
| 01/11/2012 | CN101485643B Plant hollow capsule |
| 01/11/2012 | CN101417072B Effervescence tablet for treating gynecologic disease |
| 01/11/2012 | CN101400343B Modified release formulations containing drug-ion exchange resin complexes |
| 01/11/2012 | CN101307317B Method for preparing rabies virus antigen |
| 01/11/2012 | CN101229366B Applications of fibroblast growth factor on preparing vasculogenesis-promoting medicine |
| 01/11/2012 | CN101108250B Mono- and disaccharide derivatives |
| 01/11/2012 | CN101045083B Dizziness-clearing soft capsule, its preparing method and detection method |
| 01/11/2012 | CN101031283B Pharmaceutical compositions for drug delivery |
| 01/11/2012 | CN101005828B Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| 01/10/2012 | US8093289 Oral composition comprising 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionic acid or salt thereof |
| 01/10/2012 | US8093286 Methods for treatment with bucindolol based on genetic targeting |
| 01/10/2012 | US8093230 Supersaturated aqueous ifosfamide compositions |
| 01/10/2012 | US8093215 Method for restructuring a biological tissue comprising collagen fibrils and relative uses |
| 01/10/2012 | US8093207 Fast-acting oral peptide pharmaceutical products |
| 01/10/2012 | US8093203 Method of enhancing fragrance by adding optically active muscone composition |
| 01/10/2012 | US8092833 Compositions containing inclusion complexes |
| 01/10/2012 | US8092830 Lactic acid polymer and process for producing the same |
| 01/10/2012 | US8092827 Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same, and process for producing medical non-crosslinked pressure-sensitive adhesive composition |
| 01/10/2012 | US8092826 Partially hydrogenated vegetable oils or saturated fats suppress unpleasant mouthfeel of botanicals such as Echinacea in a confectionary base, such as in nutraceuticals |
| 01/10/2012 | US8092818 Medical devices having bioactive surfaces |
| 01/10/2012 | US8092795 Liquid seasoning |
| 01/10/2012 | US8092788 Compositions and methods for topical diagnostic and therapeutic transport |
| 01/10/2012 | US8092780 Polyvalent conjugate vaccine for cancer |
| 01/10/2012 | US8091801 Generation of therapeutic microfoam |
| 01/10/2012 | CA2633027C Adhesive pharmaceutical preparation |
| 01/10/2012 | CA2530117C Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix |
| 01/10/2012 | CA2503719C Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases |
| 01/10/2012 | CA2486553C Ibuprofen suspension |
| 01/10/2012 | CA2464334C Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/10/2012 | CA2444692C Use of neuronal sodium channel antagonists for the control of ectoparasites in homeothermic animals |
| 01/10/2012 | CA2428144C Compositions of interferon-beta stabilized with highly purified mannitol |
| 01/10/2012 | CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/10/2012 | CA2392071C Microparticle-based transfection and activation of dendritic cells |
| 01/10/2012 | CA2348540C Transdermal delivery of medications using a combination of penetration enhancers |
| 01/10/2012 | CA2348167C Pharmaceutical administration form for peptides, process for its preparation, and use |
| 01/10/2012 | CA2334483C Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |